Company Name, Ticker, Industry, else..

Oncorus Inc (NASDAQ: ONCR)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Oncorus Inc 's

Name: Oncorus Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ONCR Sales vs. its Competitors Q1 2023

Comparing the current results to its competitors, Oncorus Inc reported Revenue decrease in the 1 quarter 2023 year on year by 0 %, slower than the combined decrease of the ONCR's competitors by -24.66 %, recorded in the same quarter.

• List of ONCR Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Oncorus Inc , slower than the average decrease reported by the company's competitors of -42.76 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -42.76 %

<< ONCR Stock Performance Comparisons

<< See the full list of ONCR competitors

*Market share is calculated based on total revenue.

ONCR's Stock Performance relative to its Competitors

Publicly Traded Peers of Oncorus Inc

Ideaya Biosciences Inc
Share Performance

-12.41%

30 Days

Ideaya Biosciences Inc

Profile

Ideaya Biosciences Inc operates on a precision medicine approach that combines genomics and synthetic lethality to develop targeted cancer therapies. The company focuses on identifying synthetic lethal interactions in cancer and leveraging these insights to discover and develop drugs that selectively target cancer cells. They collaborate with academic institutions and industry partners to advance their therapeutic pipeline and bring innovative treatments to patients in need.

More about Ideaya Biosciences Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 3,352.878 mill.	$ 234.127 mill.	$ -175.020 mill.

Mira Pharmaceuticals Inc
Share Performance

-41.61%

This Year

Mira Pharmaceuticals Inc

Profile

Mira Pharmaceuticals Inc's business model is focused on the development and sale of pharmaceutical products, with a particular emphasis on research and innovation in the healthcare industry.

More about Mira Pharmaceuticals Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 36.559 mill.	$ - mill.	$ -9.480 mill.

Milestone Pharmaceuticals Inc
Share Performance

-62.65%

This Year

Milestone Pharmaceuticals Inc

Profile

Milestone Pharmaceuticals Inc. is a pharmaceutical company that focuses on developing and commercializing innovative therapies for cardiovascular diseases. Their business model revolves around identifying unmet medical needs in the cardiovascular space and leveraging their expertise in drug development to create novel treatments. By conducting rigorous research, clinical trials, and collaborations, Milestone Pharmaceuticals aims to bring effective and safe medications to market, positively impacting patients' lives.

More about Milestone Pharmaceuticals Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 95.316 mill.	$ 2.343 mill.	$ -84.011 mill.

Moonlake Immunotherapeutics
Share Performance

-40.80%

This Quarter

Moonlake Immunotherapeutics

Profile

Moonlake Immunotherapeutics's business model revolves around the development and commercialization of innovative immunotherapies for the treatment of diseases.

More about Moonlake Immunotherapeutics's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 875.157 mill.	$ - mill.	$ -265.223 mill.

Medicure Inc
Share Performance

0.00%

30 Days

Medicure Inc

Profile

Medicure Inc operates as a pharmaceutical company with a business model that focuses on the research, development, and commercialization of innovative cardiovascular and other specialty pharmaceuticals. They aim to address unmet medical needs, improve patient outcomes, and deliver value to healthcare providers and consumers.

More about Medicure Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ - mill.	$ 25.925 mill.	$ -5.920 mill.

98 more competitors available

Sources: Oncorus Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 18, 2026 5:33 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Oncorus Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.